NexCure partners with health systems to build and operate outpatient treatment centers focused on CAR-T and T-cell engagers. It aims to close the infrastructure gap so more patients can receive advanced cancer therapies.
Funding
All fundraising announcements are based on public sources. Please contact Cosign if you believe there are any discrepancies, or claim the profile to edit.
Leads
Participating Firms
Angels
Series A
$19M
Led by
RA Capital Management